Two Case Report of Obesity with atopic dermatitis Treated with Hwangryunhaedoktang-gamibang

Eung-Su Lee; Hye-Lin Woo; Kyoung-Sun Park; Deok-Sang Hwang; Chang-Hoon Lee; Jun-Bok Jang; Jin-Moo Lee; Lee, Eung-Su; Woo, Hye-Lin; Park, Kyoung-Sun; Hwang, Deok-Sang; Lee, Chang-Hoon; Jang, Jun-Bok; Lee, Jin-Moo

doi:10.13048/jkm.18027

JKM > Volume 39(3); 2018 > Article

Lee, Woo, Park, Hwang, Lee, Jang, and Lee: Two Case Report of Obesity with atopic dermatitis Treated with Hwangryunhaedoktang-gamibang

Case Report

The Journal of Korean Medicine 2018; 39(3): 81-88.

Published online: September 30, 2018

DOI: https://doi.org/10.13048/jkm.18027

Two Case Report of Obesity with atopic dermatitis Treated with Hwangryunhaedoktang-gamibang

Eung-Su Lee¹

, Hye-Lin Woo¹

, Kyoung-Sun Park², Deok-Sang Hwang², Chang-Hoon Lee², Jun-Bok Jang², Jin-Moo Lee²

¹Dept. of Clinical Korean Medicine Graduate School, Kyung-Hee University

²Dept. of Gynecology, College of Korean Medicine, Kyung-Hee University

Correspondence to：이진무(Jin-Moo Lee) 경희대학교 한의과대학 부인과 교실 Tel: +82-2-440-6230, Fax: +82-2-440-6296, E-mail: hanbang9597@hamail.net

Received August 23, 2018 Revised September 10, 2018 Accepted September 10, 2018

Abstract

Objectives

This study was performed1 to assess the effectiveness of HwangryunHaedokTang-gamibang on Obesity with atopic dermatitis.

Methods

Patients were treated by HwangryunHaedokTang-gamibang. To measure treatment outcomes, BMI, weight, Fat mass, Fat %, VAS scale, SCORAD index were used.

Results

After treatment, BMI, weight, Fat mass, Fat% were significantly decreased. Atopic dermatitis VAS and SCORAD index were also decreased at all cases.

Conclusions

HwangryunHaedokTang-gamibang may be effective in the treatment of Obesity with atopic dermatitis patients.

Keywords: Obesity, Atopic dermatitis, HwangryunHaedokTang-gamibang, Case-report

Table 1

Composition of HwangryunHaedokTang-gamibang I and II

Prescription	黃連解毒湯加味方I	黃連解毒湯加味方II
Composition		薏苡仁 12g
	黃連黃芩黃柏梔子各 5g	黃連黃芩黃柏梔子各 5g
	葛根白芍藥升麻甘草玄	葛根白芍藥升麻甘草玄
	蔘荊芥防風蟬退各	蔘荊芥防風蟬退各
	2.625g	2.625g

Table 2

The Progress of Treatment(Case 1)

Visit	Progress						Prescription
Visit	Body Weight (kg)	BMI (kg/m²)	FAT percent	FAT mass (kg)	VAS of Pruritus	SCORAD index	Prescription
1st visit 2017-04-06	62.3	24.0	30.4%	18.9	VAS 8	47.3	黃連解毒湯加味方I
2nd visit 2017-06-29	60.0	23.1	28.3%	17.0	VAS 5	24.3	黃連解毒湯加味方I
3rd visit 2017-09-15	57.2	22.1	27.1%	15.5	VAS 3	7.6	黃連解毒湯加味方I
4th visit 2017-10-10	57.5	22.2	27.2 %	15.6	-	3.7	黃連解毒湯加味方II

Table 3

The Progress of Treatment(Case 2)

Visit	Progress						Prescription
Visit	Body Weight (kg)	BMI (kg/m²)	FAT%	FAT mass (kg)	VAS of Pruritus (Face/finger)	SCORAD index	Prescription
1st visit 2017-06-02	67.9	24.6	33.0%	22.4	VAS 10/VAS 10	87.7	黃連解毒湯加味方I
2nd visit 2017-07-29	65.0	23.6	32.6%	21.2	VAS 7/VAS 6	70.3	黃連解毒湯加味方I
3rd visit 2017-09-15	64.1	23.3	30.7%	19.7	VAS 5/VAS 3	47	黃連解毒湯加味方II

참고문헌

1. Statistics Korea. Experiences of atopic dermatitis diagnosis: sex, age 19 and over. Korean Statistical Information Service. [cited 2018 Jun 29]. 1:1. [1 screen]. Available at: URL:http://kosis.kr/statisticsList/statisticsListIndex.do?menuId=M_01_01&vwcd=MT_ZTITLE&parmTabId=M_01_01#SelectStatsBoxDiv

2. Smith CH. New approaches to topical therapy. Clin Exp Deruratol. 2000; 25:567–74.

3. Cho MS, Han CJ, Kim YH. The Use of Oriental Medicine for Pediatric Outpatients with Atopic Dermatitis. J Pediatr Korean Med. 2011; 25:2. 8–14.

4. Chen Y, Rennie D, Cormier Y, Dosman J. Association between Obesity and Atopy in Adults. Int Arch Allergy Immunol. 2010; 153:372–7.

5. Boulet LP. Obesity and atopy. Clin Exp Allergy. 2015; 45:1. 75–86.

6. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004; 363:9403. 157–63.

7. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. The Lancet. 2007; 369:9555. 71–7.

8. Kim YH. Overview for Pattern and Results of Herbal Medicine-derived Atopic Dermatitis Clinical Researches. J Korean Orient Pediatr. 2012; 26:2. 53–61.

9. Kim BA, Kim MS, Kang BM, Byeon SH, Park IH, Park JH, et al. Inhibitory Studies of Hwangryunhaedok-tang on Development of Atopic Dermatitis in NC/Nga Mice. Kor J Herbology. 2008; 23:2. 59–65.

10. Yamakawa J, Ishigaki Y, Takano F, Takahashi T, Yoshida J, Moriya J, et al. The Kampo medicines Orengedokuto, Bofutsushosan and Boiogito have different activities to regulate gene expressions in differentiated rat white adipocytes: comprehensive analysis of genetic profiles. Biol Pharm Bull. 2008; 31:11. 2083–9.

11. Lee HL. Atopic Dermatitis. Korean J Pediatr. 2000; 43:9. 1161–7.

12. Cha KB, Kim YS, Seol IC. Literatual study on Atopic dermatitis. Journal of Haehwa Medicine. 2005; 14:2. 113–26.

13. Kang RY, Park BK, Gim SB, Choi HJ, Kim DH. The effects of HYT on various immunological factors related to pathogenesis of allergic dermatitis in NC/Nga mice induced by Biostir AD. Journal of Haehwa Medicine. 2009; 18:2. 47–62.

14. Park MC, Choi IH. The Efficacy of Sihocheonggan-san(Chaihuqinggan-san) Extract to Improve the Function of Stratum Corneum on Mice Model after Atopic Dermatitis Elicitation. J Korean Oriental Med. 2004; 25:3. 137–48.

15. Ki HP, Jang SI, Yun YG. Ameliorative Effects of Hwangnyeonhaedok-tang on Atopic Dermatitis. Herbal Formula Science. 2013; 21:1. 80–90.

16. Nagatani S, Guthikonda P, Thompson RC, Tsukamura H, Maeda KI, Foster DL. Evidence for GnRH regulation by leptin: leptin administration prevents reduced LH secretion during fasting. Neuroendocrinology. 1998; 67:370–6.

17. Moon SJ, Kong JC, Kwon YD, Song YS, Han AR, Kwon YM, et al. Review of Clinical Studies on Oriental Medicine Treatment for Obesity in the Korean Literature. KOREAN JOURNAL OF ORIENTAL MEDICINE. 2010; 16:3. 85–93.

18. Ge H. Zhouhou Beiji Fang. Handbook of Prescriptions for Emergency. Taipei: People’s Health Publishing House;1996. p. 34–7.

19. Kim HK, Shin SW, Park JH. Inhibitory Effect of Galgeunhaegi-Tang on Compound 48/80 stimulated Allergic Reaction. JPPKM. 2009; 23: 2. 381–8.

20. Lim SC. Effects of Yullmoo (Coix lachryma-jobi var. mayuen stapf.) ext. on Lipidlowering and Serum Glucose in Hyperlipidemic Rat. Korean J Plant Res. 2006; 19:2. 126–9.